AmerisourceBergen Corp. said Monday it has agreed to acquire PharmaLex Holding GmbH, a German company offering specialized services for the life sciences industry, or 1.28 billion euros ($1.29 billion) in cash. The deal "will advance AmerisourceBergen's role as partner of choice for biopharmaceutical manufacturers by enhancing AmerisourceBergen's global portfolio of solutions to support manufacturer partners across the pharmaceutical development and commercialization journey," the company said in a statement. The deal is expected to close by March of 2023 and to boost AmerisourceBergen's adjusted per-share earnings for the last seven months of fiscal 2023 by 15 cents. AmerisourceBergen is a distributor of drugs and healthcare products. Shares were not yet active premarket, but have gained 11% in the year to date, while the S&P 500 has fallen 15%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
